Skip to main content

and
  1. No Access

    Article

    Does addition of glucocorticoids to the initial therapy influence the later course of the disease in patients with early RA? Results from the Swiss prospective observational registry (SCQM)

    The main goal of this study was to analyse whether initial addition of glucocorticoid to DMARD therapy influences the long-term course of the disease in patients with early rheumatoid arthritis. All patients f...

    Ruediger B. Mueller, Nazim Reshiti, Toni Kaegi, Axel Finckh in Clinical Rheumatology (2017)

  2. Article

    Open Access

    Improving the primary care physicians' decision making for fibromyalgia in clinical practice: development and validation of the Fibromyalgia Detection (FibroDetect®) screening tool

    Fibromyalgia diagnosis is a challenging and long process, especially among primary care physicians (PCPs), because of symptom heterogeneity, co-morbidities and clinical overlap with other disorders. The purpos...

    Ralf Baron, Serge Perrot, Isabelle Guillemin in Health and Quality of Life Outcomes (2014)

  3. Article

    Open Access

    Long-term tolerability and maintenance of therapeutic response to sodium oxybate in an open-label extension study in patients with fibromyalgia

    The long-term safety and therapeutic response of sodium oxybate (SXB) in fibromyalgia syndrome (FM) patients were assessed for a combined period of up to 1 year in a prospective, multicenter, open-label, exten...

    Michael Spaeth, Cayetano Alegre, Serge Perrot in Arthritis Research & Therapy (2013)

  4. No Access

    Reference Work Entry In depth

    Tender Points

    Michael Spaeth in Encyclopedia of Pain (2013)

  5. Article

    Epidemiology, costs, and the economic burden of fibromyalgia

    The assumption that fibromyalgia is associated with a major impact on the utilization of both healthcare and nonhealthcare resources has not been thoroughly supported by evidence-based data. Despite the differ...

    Michael Spaeth in Arthritis Research & Therapy (2009)

  6. No Access

    Article

    Is pregabalin a safe and effective treatment for patients with fibromyalgia?

    The concept of fibromyalgia being one of several 'central sensitivity syndromes' has led to the use of centrally acting drugs in the treatment of this disorder. One such drug, pregabalin, has recently been app...

    Michael Spaeth in Nature Clinical Practice Rheumatology (2008)

  7. Article

    Biology and therapy of fibromyalgia. Evidence-based biomarkers for fibromyalgia syndrome

    Researchers studying fibromyalgia strive to identify objective, measurable biomarkers that may identify susceptible individuals, may facilitate diagnosis, or that parallel activity of the disease. Candidate ob...

    Dina Dadabhoy, Leslie J Crofford, Michael Spaeth in Arthritis Research & Therapy (2008)

  8. No Access

    Reference Work Entry In depth

    Tender Points

    Michael Spaeth in Encyclopedia of Pain (2007)